Skip Navigation

Cardiovascular Research 1999 42(1):201-205; doi:10.1016/S0008-6363(98)00326-5
© 1999 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Marano, G.
Right arrow Articles by Ferrari, A. U
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marano, G.
Right arrow Articles by Ferrari, A. U
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1999, European Society of Cardiology

Sympathectomy inhibits the vasoactive effects of nicotine in conscious rats

Giuseppe Maranoa,*, Agustin Ramirezb, Ileana Morib and Alberto U Ferrarib,c

aLaboratorio di Farmacologia, Istituto Superiore di Sanitá, Viale Regina Elena 299, 00161 Roma, Italy
bCentro di Fisiologia Clinica e Ipertensione, Cattedra di Cardioangiologia Medica, Università di Milano; Ospedale Maggiore, and CNR, Milano, Italy
cDivisione di Cardioriabilitazione, Ospedale di Seregno, Az. Osp. Civ., Vimercate (MI), Italy

* Corresponding author. Tel.: +39-6-4990-2395; fax: 39-6-4938-7104. E-mail address: gmarano@net.iss.it (A.U. Ferrari)

Objective: The mechanisms underlying the pressor response to nicotine are incompletely understood. Although sympatho-adrenergic activation plays a major role, the relative contribution of adrenal vs. neurally released catecholamines and the possible role of non-adrenergic factors (e.g. vasopressin release) is not established. Methods: We examined the cardiovascular responses to graded i.v. injections of nicotine (1 to 100 µg kg–1) in conscious Wistar–Kyoto rats under control conditions and (i) after chemical sympathectomy by 6-hydroxydopamine, which destroys sympathetic endings but spares the adrenal medulla; (ii) after an {alpha}-adrenergic blockade by phenoxybenzamine; (iii) after a V1 vasopressin receptor blockade by a specific antagonist. Results: In control rats, nicotine caused a dose-dependent tachycardiac and pressor response. Both responses were abolished by sympathectomy, whereas the {alpha}-blockade left the tachycardiac response unaffected but inhibited the pressor response; the V1 vasopressin receptor blockade had no effect on either the tachycardiac or pressor response. Conclusions: We conclude that in the conscious rat: (1) the pressor response to nicotine mainly depends on peripheral {alpha}-adrenergically-mediated vasoconstriction; (2) the vasomotor effect is caused by neural rather than adrenomedullary catecholamine release; (3) the nicotine-induced increase in heart rate (and presumably cardiac output) is per se unable to raise blood pressure, and (4) the nicotine-induced release of vasopressin plays no significant role in the pressor response.

KEYWORDS Nicotine; Blood pressure; Heart rate; Sympathectomy; Arginine–vasopressin; Adrenal catecholamines


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
S. Ji, T. Tosaka, B. H. Whitfield, A. N. Katchman, A. Kandil, B. C. Knollmann, and S. N. Ebert
Differential Rate Responses to Nicotine in Rat Heart: Evidence for Two Classes of Nicotinic Receptors
J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 893 - 899.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. S. Broide, R. Salas, D. Ji, R. Paylor, J. W. Patrick, J. A. Dani, and M. De Biasi
Increased Sensitivity to Nicotine-Induced Seizures in Mice Expressing the L250T alpha 7 Nicotinic Acetylcholine Receptor Mutation
Mol. Pharmacol., March 1, 2002; 61(3): 695 - 705.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.